Early Data Show Moderna’s Coronavirus Vaccine Is 94.5% Effective

Moderna is the second company to report preliminary results from a large trial testing a vaccine. But there are still months to go before it will be widely available to the public. By Denise Grady from NYT Health https://ift.tt/2II31F4